bisoprolol has been researched along with Malignant Hypertension in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubin, S | 1 |
| Lacraz, A | 1 |
| Galantine, V | 1 |
| Gosse, P | 1 |
| Tomek, M | 1 |
| Nandoskar, A | 1 |
| Chapman, N | 1 |
| Gabriel, C | 1 |
2 other studies available for bisoprolol and Malignant Hypertension
| Article | Year |
|---|---|
Malignant hypertension and interferon-beta: a case report.
Topics: Adult; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Bisoprolol; Female; Humans; Hypertensi | 2014 |
Facial nerve palsy in the setting of malignant hypertension: a link not to be missed.
Topics: Adult; Antihypertensive Agents; Bell Palsy; Bendroflumethiazide; Bisoprolol; Facial Nerve; Facial Pa | 2015 |